The treatment for most patients with early‐stage cervical cancer involves radical
hysterectomy and pelvic lymph node dissection, and indications for postoperative adjuvant …

Cervical cancer is the fourth most common cancer in women worldwide. The preferred
treatment for early stage cervical cancer is radical hysterectomy with pelvic lymph node …

Objectives There is no consensus on whether giving adjuvant concurrent
chemoradiotherapy (CCRT) is more effective than adjuvant radiotherapy (RT) alone in …

Objective To estimate the effect of adjuvant chemotherapy (AC) on the prognosis in cervical
cancer patients with intermediate-or high-risk factors after radical hysterectomy (RH) …

Background The standard treatment for stage IB–IIB cervical cancer is radiotherapy or
radical hysterectomy; after radical hysterectomy, adjuvant concurrent chemoradiotherapy is …

Objectives To identify groups of patients who derive clinical benefit from postoperative
adjuvant concurrent chemoradiotherapy (CCRT), we retrospectively investigated the survival …

Importance There is no current consensus on the role of chemotherapy in addition to
radiation for postoperative adjuvant treatment of patients with early-stage cervical cancer …

Objective Adjuvant treatment remains a controversial issue for intermediate-risk cervical
cancer. The aim of this study was to compare the prognosis of patients who underwent no …

Background At present, extensive hysterectomy and pelvic lymph node dissection are
preferred for early-stage cervical cancer. However, additional adjuvant therapy could be …

Abstract Purpose The Gynecologic Oncology group (GOG) 0263 trial is currently exploring
whether adding chemotherapy to adjuvant radiotherapy improves recurrence-free and/or …